| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |